Prevymis (letermovir) - Merck (MSD)
Real-world effectiveness of extended use of letermovir among adult allogeneic haematopoietic cell transplant recipients: a systematic review and meta-analysis of observational studies (ESCMID Global 2026) - Feb 4, 2026 - Abstract #E0041; Pres time: Apr 18, 2026; 08:36 AM - 08:42 AM; Location: Arena 2; No abstract available 
Observational data • Real-world • Real-world effectiveness • Real-world evidence • Retrospective data • Review • Transplantation
https://www.escmid.org/congress-events/escmid-global/programme/preliminary-programme/
 
R. Chemaly; A. Vyas; H. Appaneal; A. Beyer
 
Feb 4, 2026
 
Prev Next